L3VLUP
ProSign in

ADPT · GILD in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ADPTGILD
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ADPT
  • GILD
010203040202120222023202420252026
Holders and value by quarter
QuarterADPTGILD
Q3 202011 holders, $2.2bn25 holders, $14.2bn
Q4 202010 holders, $2.7bn27 holders, $13.4bn
Q1 20216 holders, $1.9bn24 holders, $14.5bn
Q2 20217 holders, $2.0bn18 holders, $14.9bn
Q3 20217 holders, $1.7bn20 holders, $16.4bn
Q4 20217 holders, $1.5bn20 holders, $16.8bn
Q1 20225 holders, $525m28 holders, $13.2bn
Q2 20223 holders, $311m26 holders, $13.6bn
Q3 20223 holders, $281m24 holders, $13.3bn
Q4 20223 holders, $300m32 holders, $21.1bn
Q1 20233 holders, $347m27 holders, $21.8bn
Q2 20233 holders, $272m24 holders, $20.7bn
Q3 20234 holders, $262m24 holders, $20.0bn
Q4 20235 holders, $232m22 holders, $21.5bn
Q1 20243 holders, $131m30 holders, $20.3bn
Q2 20243 holders, $151m28 holders, $18.5bn
Q3 20243 holders, $214m29 holders, $24.2bn
Q4 20244 holders, $239m28 holders, $25.9bn
Q1 20253 holders, $283m33 holders, $32.0bn
Q2 20255 holders, $404m27 holders, $30.9bn
Q3 20255 holders, $503m23 holders, $29.4bn
Q4 20256 holders, $535m25 holders, $34.3bn
Q1 20266 holders, $457m25 holders, $38.5bn
Q2 20267 holders, $946m26 holders, $34.2bn
ADPT

Adaptive Biotechnologies Corp

Holders
4
Reported value
$239m
Buyers
2
Sellers
1

Breadth +1 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
GILD

Gilead Sciences Inc

Holders
28
Reported value
$25.9bn
Buyers
14
Sellers
14

Breadth 0 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q4 2024

Among the 30 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ADPT (2)

ARK Investment Management LLC, Viking Global Investors LP

Only GILD (26)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Point72 Asset Management LP, Renaissance Technologies LLC, Schonfeld Strategic Advisors LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, Wellington Management Group LLP, Winton Group Ltd, and 1 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →